abstract: A sperm-specific phospholipase C-zeta (PLCz) is believed to play an essential role in oocyte activation during mammalian fertilization. Sperm PLCz has been shown to trigger a prolonged series of repetitive Ca 2+ transients or oscillations in oocytes that precede activation.
Introduction
At fertilization, the first event following the fusion of the sperm and oocyte membranes is a series of transient rises in the intracellular-free Ca 2+ concentration, termed Ca 2+ oscillations. In human and other oocytes, these Ca 2+ oscillations persist for several hours after gamete fusion (Miyazaki et al., 1993) . Prolonged Ca 2+ oscillations have also been observed after intra-cytoplasmic sperm injection (ICSI) in both human and mouse oocytes (Tesarik et al., 1994; Nakano et al., 1997) . In all species studied, such Ca 2+ oscillations are both necessary and sufficient for the completion of all the events of oocyte activation and early embryonic development (Nomikos et al., 2012) . Ca 2+ oscillations in mammalian oocytes occur as a result of inositol trisphosphate (IP 3 )-mediated Ca 2+ release from internal stores such as the endoplasmic reticulum (ER) (Miyazaki et al., 1992) , with the amplitude, duration and frequency of Ca 2+ oscillations being largely species specific (Swann et al., 2006; Nomikos et al., 2012) . However, the sperm factor causing the Ca 2+ oscillations is not species specific because the injection of human sperm into mouse oocytes can cause Ca 2+ oscillations as well as oocyte activation (Vanden Meerschaut et al., 2013) . Since it is the Ca 2+ oscillations that trigger embryo development, the outcome of such heterologous ICSI has been suggested as a method for evaluating cases of oocyte activation failure after human ICSI (Vanden Meerschaut et al., 2013) . Over the past decade, mounting experimental and clinical evidence suggests that the factor responsible for the initiation of Ca 2+ oscillations during mammalian fertilization is a testis-specific isoform of phospholipase C (PLC), PLC-zeta (PLCz) Saunders et al., 2002; Kouchi et al., 2004; Yoon et al., 2008; Heytens et al., 2009; Kashir et al., 2010) . Sperm-delivered PLCz is believed to catalyse phosphatidylinositol 4,5-bisphosphate (PIP 2 ) hydrolysis within the fertilized oocyte, stimulating the inositol 1,4,5-trisphosphate (InsP 3 ) signalling pathway leading to Ca 2+ oscillations Nomikos et al., 2012) . The significance of PLCz in human fertilization has been emphasized by recent clinical studies that have linked abnormal expression, localization and defects in PLCz protein structure with cases of oocyte activation deficiency and subsequently with male infertility (Yoon et al., 2008; Heytens et al., 2009; Nomikos et al., 2011a; Kashir et al., 2012) . Human sperm lacking PLCz have also been shown to be deficient in causing Ca 2+ oscillations in heterologous ICSI with mouse oocytes (Yoon et al., 2008) . The clinical potential of PLCz was also recently highlighted by the use of recombinant human PLCz protein . It was demonstrated that in a prototype of male factor infertility, microinjection of recombinant human PLCz could phenotypically rescue failed activation of mouse oocytes expressing dysfunctional PLCz, leading to efficient blastocyst formation . Similar to other PLC isoforms, PLCz demonstrates a typical PLC domain structure with four tandem EF-hand domains at the N-terminus, followed by the characteristic X and Y catalytic domains, which form the active site in all PLC isoforms, and a single C2 domain at the C-terminus . Each of the individual PLCz domains appears to have an essential role in the distinct biochemical characteristics and the unique mode of regulation of this gamete-specific PLC isozyme (Nomikos et al., 2005 (Nomikos et al., , 2007 (Nomikos et al., , 2011b . A major difference of the sperm PLCz to somatic cell PLC isoforms is the absence of a pleckstrin homology domain . This makes PLCz the smallest known mammalian PLC with a molecular mass of 70 kDa in humans and 74 kDa in mice Saunders et al., 2002) . Notably, there appear to be substantial differences in the relative potency of PLCz from different species (Swann et al., 2006; Saunders et al., 2007; Cooney et al., 2010; Bedford-Guaus et al., 2011) . Previous reports have suggested that it takes nearly .10 times less human PLCz cRNA than mouse PLCz cRNA to trigger Ca 2+ oscillations in mouse oocytes . These species differences in PLCz effectiveness may explain why even 'dead' human sperm can still be shown to cause some Ca 2+ oscillations in mouse oocytes (Yazawa et al., 2009) . However, the expression levels have not been carefully measured in the same set of experiments with both mouse and human PLCz and so the precise difference in potency between these species is not clear. There have also been no parallel studies of the comparative in vitro enzymatic characteristics of recombinant human and mouse PLCz. In addition, the domain(s) of human PLCz that might contribute significantly to the greater potency of human PLCz are currently unknown.
In the present study, we provide a quantitative and qualitative comparison of the relative potencies of human and mouse PLCz by using luciferase-tagged fusion proteins, and by using this approach we have determined the specific degree to which human PLCz is more effective than mouse PLCz in generating Ca 2+ oscillations in mouse oocytes.
Recombinant human PLCz also displayed a higher in vitro PIP 2 hydrolysis activity than mouse PLCz. By preparing human/mouse PLCz domain 'swaps', this has enabled chimeric protein analysis to demonstrate that replacement of the human PLCz C2 domain with the corresponding mouse C2 domain did not alter the in vitro and in vivo enzymatic properties of human PLCz. However, exchanging the human for mouse EF-hand domain reduced the Ca 2+ oscillation-inducing activity by altering the Ca 2+ sensitivity and affinity of human PLCz for PIP 2 . Finally, our data suggest that replacement of the human PLCz XY-linker with the corresponding region of mouse PLCz dramatically affects the stability of the protein, suggesting a significant role of the XY-linker region in speciesspecific differences in PLCz Ca 2+ oscillation-inducing activity.
Materials and Methods

Cloning of PLCz human -mouse chimeric constructs
The hPLCz/mEF-luc and hPLCz/mC2-luc constructs were cloned into pCR3 vector by using a three-step cloning strategy. All the above chimeric constructs without the C ′ -terminus luciferase were amplified from the pCR3 vector with the appropriate primers to incorporate a 5 ′ -SalI site and a 3 ′ -NotI site and cloned into the pETMM60 vector to enable bacterial protein expression. Each of the above expression vector constructs was confirmed by dideoxynucleotide sequencing (Prism Big Dye kit; ABI Prism w 3100 Genetic Analyzer, Applied Biosystems, Warrington, UK).
cRNA synthesis
Following linearization of wild-type and chimeric PLCz plasmids, cRNA was synthesized using the mMessage Machine T7 kit (Ambion) and then was polyadenylated using the poly(A) tailing kit (Ambion), as per the manufacturer's instructions.
Preparation and handling of gametes
Female mice were superovulated and oocytes were collected 13.5-14.5 h after injection of human chorionic gonadotrophin and maintained in droplets of M2 media (Sigma) or H-synthetic oviductal medium enriched with potassium (KSOM) under mineral oil at 378C. Microinjection of the oocytes was carried out 14.5 -15.5 h after the hormone injection. Experimental recordings of Ca 2+ or luciferase expression were carried out with mouse oocytes in HEPES-buffered media (H-KSOM) as described previously (Nomikos et al., 2005 (Nomikos et al., , 2011b (Nomikos et al., , c, 2013 . All compounds were from Sigma unless stated otherwise. All procedures using animals were performed in accordance with the UK Home Office Animals Procedures Act and were approved by the Cardiff University Animals Ethics Committee.
Microinjection and measurement of intracellular Ca 21 and luciferase expression
Mouse oocytes were washed in M2 and microinjected with cRNA diluted in injection buffer (120 mM KCl, 20 mM HEPES, pH 7.4). The volume injected was estimated from the diameter of cytoplasmic displacement caused by the bolus injection. All injections were 3 -5% of the oocyte volume. Oocytes were microinjected with the appropriate cRNA, mixed with an equal volume of 1 mM Oregon Green BAPTA dextran (Molecular Probes) in the injection buffer. Oocytes were then maintained in H-KSOM containing 100 mM luciferin and imaged on a Nikon TE2000 or Zeiss Axiovert 100 microscope equipped with a cooled intensified charge-coupled device camera (Photek Ltd., UK). The luminescence (for luciferase expression) and fluorescence (for Ca 2+ measurements) from eggs were collected by switching back and forth between two modes on a 10 s cycle (Swann et al., 2009; Nomikos et al., 2011a ). These two signals are then displayed as two separate signals over the same time period. The fluorescent light used to measure Ca 2+ is shown in relative units because we are essentially interested in the frequency or number of Ca 2+ spikes. The luminescence from oocytes was converted into an amount of luciferase using a standard curve that was generated by placing oocytes in a luminometer that had been previously calibrated by microinjection with known amounts of luciferase protein (Sigma) (Nomikos et al., 2005 (Nomikos et al., , 2011b (Nomikos et al., , c, 2013 Swann et al., 2009) . All live imaging experiments on oocytes were made during a 3-month period.
Protein expression and purification
For NusA-6xHis-fusion protein expression, Escherichia coli [Rosetta (DE3); Novagen], transformed with the appropriate pETMM60 plasmid, was cultured at 378C until A 600 reached 0.6, and protein expression was induced for 18 h, 168C with 0.1 mM isopropyl b-D-1-thiogalactopyranoside (Promega). Cells were harvested (6000 g for 10 min), resuspended in phosphate-buffered saline (PBS) containing protease inhibitor mixture (EDTA-free; Roche) and sonicated 4 × 15 s on ice. Soluble NusA-6xHisfusion protein was purified on Ni-NTA resin following standard procedures (Qiagen) and eluted with 275 mM imidazole. Eluted proteins were dialysed overnight (10 000 MWCO; Pierce) at 48C against 4 l of PBS and concentrated with centrifugal concentrators (Sartorius; 10 000 MWCO).
Assay of PLC activity
PIP 2 hydrolytic activity of recombinant PLC proteins was assayed as described previously. The final concentration of PIP 2 in the reaction mixture was 220 mM, containing 0.05 mCi of [
SDS-PAGE and western blotting
Recombinant proteins were separated by SDS-PAGE as described previously (Nomikos et al., 2011b,; . Separated proteins were transferred onto polyvinylidene difluoride membrane (Immobilon-P; Millipore) using a semi-dry transfer system (Trans-Blot SD; Bio-Rad) in buffer (48 mM Tris, 39 mM glycine, 0.0375% SDS) at 22 V for 4 h. The membrane incubated overnight at 48C in Tris-buffered saline, 0.1% Tween 20 (TBS-T) containing 5% non-fat milk powder and probed with Penta-His monoclonal antibody (1 : 5000 dilution). Detection of horseradish peroxidase-coupled secondary antibody was achieved using enhanced chemiluminescence detection (ECL; Amersham Biosciences).
Mathematical modelling
To investigate a range of mechanisms that are potentially responsible for the variable action of human and mouse isoforms of PLCz, we have employed a mathematical modelling approach. The model (outlined in detail in the Appendix) includes minor modifications from the mathatical description previously published in (Nomikos et al., 2005 (Nomikos et al., , 2011b . In addition, in order to investigate the potential importance of human PLCz domains in any species-specific differences in activity observed for human versus mouse PLCz, three chimeric plasmids were constructed. To generate these chimeric plasmids, human PLCz served as the template and then discrete protein domains were individually replaced by the corresponding domain of mouse PLCz (Fig. 1) . The three chimeric constructs comprised human PLCz containing either the EF-hand domain (hPLCz/mEF), the C2 domain (hPLCz/mC2) or the XY-linker region (hPLCz/mXYlink) from mouse PLCz (Fig. 1) . Similar to the wild-type human and mouse PLCz constructs, each of the human/mouse PLCz chimeras was tagged at the C-terminus with luciferase to enable us to verify and quantify their relative expression upon microinjection of the corresponding cRNA into mouse oocytes. As we have previously described, the advantage of this strategy is that enables realtime monitoring of the relative protein expression by luminescence quantification of the recombinant luciferase protein (Swann et al., 2009) . Figure 2 and Table I These data indicate that the wild-type human PLCz is five to six times more effective in inducing Ca 2+ oscillations compared with wild-type mouse PLCz, even in a heterologous set of oocytes. In contrast to this intrinsic difference in wild-type activity, we found that substitution of the human PLCz C2 domain with the corresponding structure from mouse PLCz did not alter the Ca 2+ oscillation-inducing activity.
However, substitution of the human PLCz EF-hand domain for that from mouse PLCz significantly reduced the Ca 2+ oscillation-inducing activity. Finally, replacement of the human PLCz XY-linker with the corresponding region of mouse PLCz appears to dramatically affect the expression levels of the chimeric PLCz in mouse oocytes.
Enzymatic characterization of human, mouse and human/mouse PLCz chimeras
Wild-type mouse PLCz and all three human/mouse chimeric PLCz constructs were subcloned into the pETMM60 vector and purified as NusA-6xHis-tagged fusion proteins. We have recently demonstrated that NusA is an effective fusion protein partner for human PLCz, significantly increasing the expression of soluble PLCz protein in E. coli, as well as enhancing the stability of the purified protein over time . Expression of active recombinant human PLCz protein has also been reported by other groups (Kashir et al., 2011; Yoon et al., 2012) . Following expression of NusA-PLCz fusion proteins in E. coli and purification by Ni-NTA affinity chromatography, the recombinant proteins were characterized. Figure 3 shows NusA-tagged wild-type human and mouse PLCz, as well as the three PLCz chimeras analysed by SDS-PAGE (upper panel) and immunoblot detection with penta-His mouse monoclonal antibody (lower panel). The major protein band with mobility corresponding to the predicted molecular mass for each construct was observed for all except the hPLCz/mXYlink chimera. These major bands were also confirmed by the penta-His antibody after immunoblot analysis ( Fig. 3; lower panel) . Interestingly, in the case of hPLCz/mXYlink chimera the major band appeared to be 103 kDa instead of the expected 133 kDa, suggesting protein degradation due to the mouse XY-linker region resulting from instability of the purified recombinant protein. This protein instability might explain the very low expression levels of this chimera in mouse oocytes.
The specific PIP 2 hydrolytic enzyme activity for each recombinant protein was determined by the standard [ Table II summarizes the enzyme specific activity values obtained for each recombinant protein. The enzymatic activities of wild-type human and mouse PLCz are in agreement with our previous observations revealing that human PLCz exhibits a 76% higher specific activity than mouse PLCz (978 + 34 versus 556 + 29 nmol/min/mg). The specific activity for hPLCz/mC2 chimera was similar to the specific activity of wild-type human PLCz (970 + 42 versus 978 + 34 nmol/min/ mg), in contrast with hPLCz/mEF chimera that showed a reduced enzymatic activity ( 20%) compared with human PLCz (782 + 33 versus 978 + 34 nmol/min/mg). In accord with the poor activity observed in oocytes, the hPLCz/mXYlink chimera did not exhibit in vitro enzymatic activity.
To (Table II) . The K m values obtained for human PLCz (75 mM), mouse PLCz (99 mM) and the hPLCz/mC2 (89 mM) chimera were quite similar. In contrast, the K m for hPLCz/ mEF chimera was 6.3-fold (475 mM) higher than that of human PLCz, suggesting that replacement of the EF hand of human from that of mouse PLCz reduces the in vitro affinity for PIP 2 .
Modelling of Ca 21 oscillations induced by human and mouse PLCz
The above data show that human PLCz is more active than mouse PLCz both in vitro and in intact oocytes. However, the differences in ability to cause Ca 2+ oscillations is more dramatic (5-to6-fold) than that for maximum enzymatic activity ( 2-fold). We employed a mathematical model of IP 3 -induced Ca 2+ oscillations to understand this apparent discrepency. The distinguishing properties that we examined were the Ca 2+ -dependence EC 50 values, PIP 2 hydrolytic activities and K m s for PIP 2 for human and mouse PLCz (Table II) . However, the main difference is that the intrinsic hydrolytic activity for human PLCz is almost twice that Ca 2+ oscillation-inducing activity (Ca 2+ spike number in 2 h) and luciferase luminescence levels (peak luminescence and luminescence at first spike) are summarized for mouse oocytes microinjected with each of the PLC-luciferase constructs (see Fig. 1A ). Values are mean + SEM.
Role of EF-hand domain in species potency of PLCz of mouse PLCz. Experimental estimates summarized in Tables I and II have been employed as parametric values in Equations (1 -3) (Appendix), while a full list of coefficient/parameter values is provided in Table III . Numerical simulations generated under these assumptions produce sustained Ca 2+ oscillations associated with the specific action of human and mouse PLCz (Fig. 5A ). In each of the two cases, we mimicked the effect of increasing expession of PLCz with time as a sigmoidal, in agreement with luminescence traces presented in Fig. 1B . Simulated traces presented in Fig. 5A closely match the Ca 2+ oscillations recorded in mouse oocytes (Fig. 2 ) both in terms of oscillatory Ca 2+ frequency (Table I ) and in terms of the protein expression level associated with onset of oscillations (Table I) . Importantly, the earlier onset of oscillatory activity for human PLCz followed by an earlier frequency saturation underlines the potential for even higher activity of the human versus mouse PLCz (possibly up to a 6-fold potency ratio). These simulations demonstrate that the different enzymatic properties we observe for the recombinant human versus mouse PLCz can explain the difference in the frequency of Ca 2+ oscillations we see in mouse oocytes.
Discussion
A growing body of evidence supports the assertion that sperm-specific PLCz is the molecule that stimulates cytoplasmic Ca 2+ oscillations at fertilization, triggering all the early events of embryo development in many mammalian species Saunders et al., 2002; Nomikos et al., 2012; Swann and Lai, 2013) . No other sperm-specific molecule has been shown to trigger Ca 2+ oscillations in mammalian oocytes. Despite recent advances in the PLCz field, which has helped us to understand the role of this sperm-derived enzyme at fertilization and its clinical potential, as a therapeutic intervention and a prognostic -dependent enzyme activity for PIP 2 hydrolysis, determined by non-linear regression analysis (GraphPad Prism 5) for the NusA-6xHis-fusion PLC proteins (see Fig. 3 ).
indicator of oocyte activation deficiency, there are still many aspects of PLCz regulatory mechanisms that need to be addressed.
There are significant species-specific differences in the relative potency of PLCz from different species (Swann et al., 2006; Saunders et al., 2007; Cooney et al., 2010; Bedford-Guaus et al., 2011) . In the present study, we have compared quantitatively and qualitatively the relative potencies of human and mouse PLCz to induce Ca 2+ oscillations in unfertilized mouse oocytes (Fig. 2) . Human PLCz caused a higher frequency of Ca 2+ oscillations even when expressed at much lower levels than mouse PLCz. This quantitatively confirms that human PLCz is more effective in generating Ca 2+ oscillations in mouse oocytes than the mouse PLCz. This remarkable difference can largely be explained by the differences in the in vitro enzymatic properties of these proteins (Fig. 3) to hydrolyse PIP 2 . In our in vitro studies, the purified human PLCz exhibited a 76% higher specific activity than mouse PLCz (978 + 34 versus 556 + 29 nmol/min/mg), however, the comparable values for EC 50 and K m (see Fig. 4 and Our chimeric analysis approach showed that replacement of the human PLCz C2 domain with its mouse counterpart had minimal effect on the in vitro enzymatic properties of human PLCz and consequently its potency to elicit Ca 2+ oscillations in unfertilized mouse oocytes. In contrast, replacement of the human PLCz EF-hand domain with that of mouse PLCz resulted in a slightly reduced enzymatic activity, but caused a 3-fold decrease in the Ca 2+ sensitivity of human PLCz, as well as a 6-fold increase in the K m value for PIP 2 , suggesting reduced substrate affinity of the enzyme. These results correlate with the reduced Ca 2+ oscillation-inducing activity of the hPLCz/mEF chimera and suggest that the EF-hand domains are not only responsible for the Ca 2+ sensitivity of PLCz but might also contribute to the enzyme substrate affinity. The most dramatic effect was observed after the replacement of the human XY-linker with the corresponding region of mouse PLCz. This substitution led to poor expression levels of hPLCz/mXYlink possibly due to significant degradation of unstable recombinant protein (Fig. 3) , which would be consistent with the low expression levels of this chimera in mouse oocytes (see Fig. 2 , Table I ). We have previously proposed that an unstructured positively charged cluster within the XY-linker region of PLCz may help anchor the protein to biological membranes through electrostatic interactions with the negatively charged PIP 2 (Nomikos et al., 2007; 2011c Role of EF-hand domain in species potency of PLCz the XY-linker region of PLCz is poorly conserved among species (Saunders et al., 2007) . Notably, the XY-linker of human PLCz is shorter in length and more positively charged than the mouse PLCz XY-linker, showing only 34.2% sequence identity and 18% similarity (see Fig. 5B ). The significance of this XY-linker diversity is still unclear, but our data suggest that this variation may contribute to the different rates of PIP 2 hydrolysis and relative potency in inducing Ca 2+ oscillations for these two species' PLCz isoform.
The full explanation of why human PLCz is more active than the mouse requires further investigation. However, we can speculate as to why the human sperm may contain a more intrinsically active enzyme. Human and mouse sperm are different in shape but not greatly different in size, and although the amount of PLCz has not been quantified in human sperm it may be similar to that of mouse sperm . If this is the case, then the human sperm faces a greater challenge in activating the oocyte. The sperm-derived PLCz is assumed to distribute evenly into the oocyte cytoplasm after gamete fusion. However, the volume of the human oocyte is about five times larger than that of the mouse oocyte, so human PLCz may have to trigger oscillations at much lower concentrations. The current study suggests that this problem may be overcome by human PLCz having at least a 5-fold greater ability to trigger Ca 2+ oscillations. Such species-dependent variation in PLCz potency may enable a precise tuning of the effective 'dose' of PLCz delivered by the sperm, which is adjusted to match the size of the recipient oocyte.
